NeurogesX Inc (NGSX) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 328 transactions totaling $62.8M, demonstrating a bullish sentiment with $5.8M in net insider flow. The most recent transaction on Jan 1, 2013 involved a transaction of 25,000 shares valued at $0.
No significant insider buying has been recorded for NGSX in the recent period.
No significant insider selling has been recorded for NGSX in the recent period.
Based on recent SEC filings, insider sentiment for NGSX is bullish with an Insider Alignment Score of 55/100 and a net flow of $5.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at NeurogesX Inc (NGSX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading NGSX stock, having executed 328 transactions in the past 90 days. The most active insider is Life Sciences Fund IV Strategic Partners L. P. Sv (Executive), who has made 8 transactions totaling $14.8M.
Get notified when executives and directors at NGSX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 1, 2013 | Martell Ron | Executive | Option Exercise | 25,000 | $N/A | $0 | |
| Dec 1, 2012 | F. Ghiglieri Stephen | Executive | Option Exercise | 3,750 | $N/A | $0 | |
| Nov 9, 2012 | J. Peroutka Stephen | Executive | Option Exercise | 18,750 | $N/A | $0 | |
| Sep 1, 2012 | F. Ghiglieri Stephen | Executive | Award | 15,000 | $0.25 | $3.8K | |
| Sep 1, 2012 | Markels Michael | Executive | Award | 15,000 | $0.25 | $3.8K | |
| Sep 1, 2012 | Markels Michael | Executive | Award | 15,000 | $0.25 | $3.8K | |
| Jan 31, 2012 | S. Goodwin Bradford | Executive | Award | 20,000 | $1.01 | $20.2K | |
| Aug 10, 2011 | Senator Ron | Executive | Sale | 82,109 | $2.00 | $164.2K | |
| Aug 10, 2011 | (1999) Ltd. M. Arkin | Executive | Sale | 82,109 | $2.00 | $164.2K | |
| Aug 9, 2011 | Senator Ron | Executive | Sale | 81,359 | $2.15 | $174.9K | |
| Aug 9, 2011 | (1999) Ltd. M. Arkin | Executive | Sale | 81,359 | $2.15 | $174.9K | |
| Jul 26, 2011 | Nelsen Robert | Executive | Purchase | 1,744,186 | $1.65 | $2.9M | Large |
| Jul 26, 2011 | F. Ghiglieri Stephen | Executive | Award | 29,069 | $1.65 | $48.0K | |
| Jul 26, 2011 | Markels Michael | Executive | Award | 29,069 | $1.65 | $48.0K | |
| Jul 26, 2011 | S. Goodwin Bradford | Executive | Award | 60,000 | $1.65 | $99.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 166 | $34.3M | 54.3% |
Sale(S) | 121 | $28.5M | 45.1% |
Award(A) | 8 | $245.6K | 0.4% |
Exercise(M) | 9 | $122.0K | 0.2% |
Gift(G) | 9 | $0 | 0.0% |
Conversion(C) | 15 | $0 | 0.0% |
Insider activity at NeurogesX Inc shows mixed signals across all time. While $34.3M in purchases indicates some executive confidence,$28.5M in sales balances the picture, resulting in a modest net flow of $5.8M.28 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Life Sciences Fund IV Strategic Partners L. P. Sv, has transacted $14.8M during this period.